Adolescents and adults aged 12 years and older who have been suffering from CSU – chronic spontaneous urticaria (hives), may qualify to participate in this study. To be eligible, participants must have itch and hives present for 6 consecutive weeks or more despite use of antihistamines, and have a CSU diagnosis for 6 months or longer.
Participants will receive investigational medication (active study drug), an active comparator or placebo via injection. Investigational medication will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 16 months and include about 19 visits to the study centre.
Call the study centre near you, or register now.
All information about you will be kept confidential.
If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.
By registering you are consenting to the terms and conditions of our privacy policy.
Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more
© 2014 All Rights Reserved Probity Medical Research Inc.